@TheFabulousOne True, it can be scary, but it can also make it safer, more affordable, and readily available for ALL patients. Pharmaceutical companies are the bigger problem in all of this - they do nothing to protect our patients.
Epidiolex, a newly-approved cannabis-derived prescription to treat certain types of epilepsy, will cost roughly $32,500/year β a price not every family may be able to afford. We need to ensure a wide variety of medical marijuana products are accessible to patients who need them.